Intellia Therapeutics, Inc NTLA
$10.68
-3.70%
at last close
Financials (TTM)
- Revenue
- $66.09 million
- Net Income
- $-394,596,000
- Net Margin
- -597.04%
- Return on Equity
- -63.55%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 2.40
- Price / Sales
- 22.58
Over the trailing twelve months, Intellia Therapeutics, Inc generated revenue of $66.09 million and net income of $-394,596,000, a net margin of -597.04%.
At the last closing price of $10.68, NTLA trades at 22.58 times sales, with a market capitalization of $1.49 billion.
Key Stats
- Last Close
- $10.68
- Market Cap
- $1.49 billion
- 52-Week Range
- $7.95 – $28.25
- Average Volume
- 4.58 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.